Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders
Biochemical and Biophysical Research Communications · 2023-11 · 682 · 1-20
DOI: 10.1016/j.bbrc.2023.09.064 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-11. Verfasst von Samradhi Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: ICMR- National Institute for Research in Environmental Health, Bhopal Bypass Road, Bhouri, Bhopal, 462030, Madhya Pradesh, India. Hauptthemen laut MEDLINE: Proteomics, Metabolic Diseases. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 226 Literaturangaben. Gefördert von: Florida Academy of Sciences, U.S. Food and Drug Administration.
Abstract (Originalsprache)
Metabolic disorders are increasingly prevalent worldwide, leading to high rates of morbidity and mortality. The variety of metabolic illnesses can be addressed through personalized medicine. The goal of personalized medicine is to give doctors the ability to anticipate the best course of treatment for patients with metabolic problems. By analyzing a patient's metabolomic, proteomic, genetic profile, and clinical data, physicians can identify relevant diagnostic, and predictive biomarkers and develop treatment plans and therapy for acute and chronic metabolic diseases. To achieve this goal, real-time modeling of clinical data and multiple omics is essential to pinpoint underlying biological mechanisms, risk factors, and possibly useful data to promote early diagnosis and prevention of complex diseases. Incorporating cutting-edge technologies like artificial intelligence and machine learning is crucial for consolidating diverse forms of data, examining multiple variables, establishing databases of clinical indicators to aid decision-making, and formulating ethical protocols to address concerns. This review article aims to explore the potential of personalized medicine utilizing omics approaches for the treatment of metabolic disorders. It focuses on the recent advancements in genomics, epigenomics, proteomics, metabolomics, and nutrigenomics, emphasizing their role in revolutionizing personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ICMR- National Institute for Research in Environmental Health, Bhopal Bypass Road, Bhouri, Bhopal, 462030, Madhya Pradesh, India.
- Stem Cell Research Centre, Department of Hematology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, 226014, Uttar Pradesh, India.
- Department of Nutrition and Integrative Physiology, College of Health and Human Sciences, Florida State University, Tallahassee, FL, 32306, USA.
- ICMR- National Institute for Research in Environmental Health, Bhopal Bypass Road, Bhouri, Bhopal, 462030, Madhya Pradesh, India. Electronic address: manoj15ndri@gmail.com.
Förderung
- Florida Academy of Sciences
- U.S. Food and Drug Administration
Zitieren
APA
Singh, S., Sarma, D. K., Verma, V., Nagpal, R., & Kumar, M. (2023). Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders. Biochemical and Biophysical Research Communications, 682, 1-20. https://doi.org/10.1016/j.bbrc.2023.09.064
Vancouver
Singh S, Sarma DK, Verma V, Nagpal R, Kumar M. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders. Biochemical and Biophysical Research Communications. 2023;682:1-20. doi:10.1016/j.bbrc.2023.09.064
BibTeX
@article{Singh2023,
author = {Singh, Samradhi and Sarma, Devojit Kumar and Verma, Vinod and Nagpal, Ravinder and Kumar, Manoj},
title = {Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
volume = {682},
pages = {1--20},
doi = {10.1016/j.bbrc.2023.09.064}
}
EUVIMED